IN8bio (NASDAQ:INAB) Stock Rating Upgraded by Wall Street Zen
IN8bio (NASDAQ:INAB – Get Free Report) was upgraded by research analysts at Wall Street Zen to a “sell” rating in a report issued on Saturday. Separately, HC Wainwright reduced their price target on IN8bio from $8.00 to $6.00 and set a “buy” rating for the company in a research report on Friday, March 14th. Read […]
IN8bio (NASDAQ:INAB – Get Free Report) was upgraded by research analysts at Wall Street Zen to a “sell” rating in a report issued on Saturday. Separately, HC Wainwright reduced their price target on IN8bio from $8.00 to $6.00 and set a “buy” rating for the company in a research report on Friday, March 14th. Read […]
